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1. BACKGROUND  
Ethiopia experiences a heavy burden of diseases with a 
growing prevalence of communicable and non-
communicable diseases. Many Ethiopians face high 
disease morbidity and mortality largely attributable to 
potentially preventable infectious diseases and nutritional 
deficiencies 
1
. 
Motherhood is a positive and fulfilling experience for 
most women. However, more than 20 million pregnancy 
and child birth are associated with suffering, ill health or 
death. Every year, approximately 8 million women 
endure pregnancy related complication(s) and half a 
million die as a result of many causes, one of which 
could be inappropriate drug use during pregnancy 
2
. 
Ethiopia's rate of maternal and newborn morbidity and 
mortality are among the highest in the world. Current 
estimate of maternal mortality stands at 673 deaths per 
100,000 live births. Direct obstetric complications 
accounted for 85% of these deaths as well as countless 
chronic conditions 
3
. 
Pregnancy is a time of profound physiological changes in 
woman's body. These unique changes challenge 
clinicians managing disease states during pregnancy in 
the selection of medications best suited to treat their 
patients. Maternal drug use during pregnancy may pose a 
teratogenic risk to the fetus and complications to the 
mother. However, the recommendation to avoid use of 
all drugs during pregnancy is unrealistic and may be 
dangerous, which depends on the risk benefit ratio to the 
mother and fetus. 
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ABSTRACT 
Objectives: To assess the extent and nature of drug utilization among pregnant women attending antenatal care in hospitals of 
Mekelle, Tigray, Ethiopia.  
Methods: Institution-based cross sectional study was conducted by reviewing the antenatal care follow up cards and 
interviewing pregnant women using semi-structured questionnaire by nurses working in the four hospitals. Details of drugs self 
utilized and prescribed during the current pregnancy were investigated and categorized according to the United States Food and 
Drug Administration fetal risk classification. Data was analyzed using SPSS version 20.0.  
Result: Of the 400 participants, majority 199 (49.8%) were in age group of 26-36years. 38 (9.5%) and 8 (2%) have self 
utilized modern and herbal drugs, respectively. Majority 26 (59.1%) were analgesics. Most 32 (84.2%) of the self medicated 
modern drugs were from category C, followed by category B. Illiterates and secondary school complete participants have 
practiced self medication 3.7 times (AOR 3.65 (1.31, 10.20), p=0.014) and 4.03 times (AOR 4.03 (1.09, 14.96), p=0.038) more 
than the tertiary complete participants, respectively. Self medication use was 3.7 times more among non government 
employees than governmental employees (AOR 3.68 (1.11, 12.17), p=0.033). Forty one (10.2%) of the participants had chronic 
diseases where most 26 (39.4%) were from category C, followed by category D 17 (25.8%). Of all the participants, 249 
(62.2%) consumed one or more prescription drugs, with 1.86±0.94 average number of drugs prescribed per pregnant women. 
Majority 190 (76.3%) were from category B, followed by category C 94 (37.8%), category A 53 (21.3%), category C/D 23 
(9.2%), category D 22 (8.8%), category B/C 7 (2.8%), category A/C 3 (1.2%) and category X 1 (0.4%).  One hundred one 
(40.6%) of the drugs were prescribed in Ayder referral hospital, followed by Mekelle 93 (37.3%), kalkidan 31 (12.4%) and 
Meskerem 24 (9.6%) hospitals. Majority of the drugs prescribed in each hospital were from category B (80 (32.1%), 71 
(28.5%), 21 (8.4%) and 18 (7.2%), respectively. Antibacterial drugs were the most commonly prescribed 146 (38.7%). 
Conclusion: Majority consumed one or more prescription drugs. Most of them were from category B. 
Keywords: pregnancy; self medications; prescription drugs, US FDA fetal risk classification, Hospitals of Mekelle. 
Gebremedhin et al                                     Journal of Drug Delivery & Therapeutics. 2014; 4(6):75-82 76 
© 2011-14, JDDT. All Rights Reserved                                                    ISSN: 2250-1177                                            CODEN (USA): JDDTAO 
Pregnancy should not deter clinicians from providing 
their patients with appropriate management of their 
medical conditions; hence prescription in pregnancy is an 
unusual risk benefit situation 
4
. 
During pregnancy, women continue to be affected by the 
usual illnesses that the non- pregnant population faces. In 
addition there are multiple conditions, some of which 
directly result from the pregnancy or are worsened by it, 
that may require pharmacologic treatment. Thus, the 
health care provider must be aware of appropriate 
pharmacologic approach for a variety of conditions and 
the potential impact on the pregnant women and the fetus 
5
. 
Careful consideration of the benefit to the mother and the 
risk to the fetus is required while prescribing drugs 
during pregnancy. Reducing medication errors and 
improving patient safety are the important areas of 
discussion 
6
. The use of drugs during pregnancy calls for 
special attention because in this case in addition to the 
mother, the health and life of her unborn child is also at 
stake. The drugs given to pregnant mothers for 
therapeutic purposes may cause serious structural and 
functional adverse effects in the developing child 
7
. Since 
it is very difficult to determine the effects on pregnant 
women and the fetus before marketing new drugs due to 
obvious ethical reasons, almost all drugs are not 
recommended to be used during pregnancy as much as 
possible, especially during the first trimester, i.e. when 
structural developments of the fetus occur 
8
.  
In developing countries people use herbal medicines 
routinely in self-care. In many countries programs exist 
that test safety and efficacy of these medicines and some 
of them are selected for inclusion in national health 
programs. However, such system does not exist in 
Ethiopia despite the wide use of herbal medicines. The 
production of herbal medicines is commercialized in 
countries such as china, India, and Thailand and 
marketing is similar to that for modern pharmaceuticals. 
But some herbal medicines are potent, and their safety is 
not as evident as people think 
9
. 
Information on the use of drugs during pregnancy is 
scarce and anecdotal. Despite the absence of adequate 
studies on safety and efficacy of drugs for pregnant 
women, evidence available shows that physicians 
prescribe, and pregnant women take a surprisingly large 
number of drugs. An international investigation 
sponsored by World Health Organization (WHO) 
showed that pregnant women ingest an average of three 
prescription medications during pregnancy (range 1-5). 
Furthermore, 86% of the women had taken at least one 
prescription medication during their pregnancies 
4
. 
The provision of complete health care necessitates the 
availability of safe, effective and affordable drugs of the 
required quality, in adequate quantity all times. The 
irrational use of drugs has become a serious problem in 
Ethiopia. Consequences of inappropriate drug use 
includes increased morbidity and mortality, increased 
risk of unwanted effects, the emergence of drug 
resistance, waste of resource, and psychosocial effects 
9
. 
In the developing world; poor health seeking behavior of 
patients, delayed initiation of antenatal care (ANC), low 
level of educational status of mothers, lack of up to date 
information of health care providers, poor access to 
health facilities, and loose control over prescription and 
non-prescription drugs could aggravate irrational use of 
drugs during pregnancy. 
Since there are numerous gaps in knowledge about 
deleterious consequences for the mother and fetus and 
the actual practice of drug use by pregnant women 
should be viewed as a public health issue. Pharmaco-
epidemiological studies can measure the extent and 
nature of drug use in pregnant women. The studies 
conducted in developed countries where drug-prescribing 
practices are considered to be superior, have identified 
need for interventional measures aimed at rational 
prescription during the prenatal period 
10
. Similar types 
of Pharmaco-epidemiological studies auditing the use of 
drugs during pregnancy have not been conducted in 
Tigray region, northern Ethiopia. Hence the aim of this 
study is to examine the extent and nature of drug 
prescription during pregnancy in four hospitals of 
mekelle town, Tigray region. With this information, this 
study intends to provide feedback and recommendations 
for the health care providers and customers (pregnant 
and potential to be pregnant). 
2. METHODOLOGY 
2.1. STUDY AREA 
Tigray is one of the nine regions in Ethiopia. It is found 
in the northern part of the country. The 2007 Gregorian 
calendar (GC) census showed the population of the 
region to be 4.3 million; of which 80 % were rural and 
50.75% of the totals are female. The region is further 
divided in to five zones including one special zone. 
These zones are Western, Central, Eastern, and southern 
Zones. The Special Zone is Mekelle Special Zone. 
According to the census; Mekelle covers 24.29 km 
square and has population of about 214,806. Mekelle is 
the capital city of Tigray. It has two governmental 
hospitals (Quiha hospital and Mekelle hospital) and one 
referral hospital (Ayder referral hospital) and three 
private hospitals (Kalkidan hospital, ben Meskerem 
hospital and Markos hospital). 
2.2. VARIABLES 
2.2.1. INDEPENDENT VARIABLES 
 Socio demographic variables (age, marital status, 
educational status and occupation ) 
 Number  of Ante Natal Care visits 
 Morbidity/acute or chronic/ 
 Level of health facility 
 Prescriber's level of training 
2.2.2. DEPENDENT VARIABLES 
 Class of drugs prescribed 
 Number of drugs prescribed per pregnant women 
 Extent of self-medication 
 Category of self utilized and prescribed drugs  
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2.3. INCLUSION AND EXCLUSION CRITERIA 
2.3.1. Inclusion criteria: participants, who were pregnant, 
willing and who visited the hospitals for ANC more than 
two times.  
2.3.2. Exclusion criteria: pregnant women, who were not 
willing and who visited the hospitals for ANC less than 
twice. 
2.4. STUDY DESIGN 
Institution based cross- sectional study was conducted to 
get the required information/data.  
2.5. SOURCE POPULATION 
The population constitutes all pregnant women who live 
in Mekelle during the study period. 
2.6. STUDY POPULATION 
All pregnant women who lived in Mekelle during the 
study period and attending antenatal care service in the 
selected hospitals during their current pregnancy. The 
study participants were sampled from the study 
population.  
2.7. SAMPLE SIZE DETERMINATION 
The sample size for the study will be determined using 
single population proportion formula. Since there is no 
data on prevalence of drug use during pregnancy in the 
region, 50% prevalence is used with 95% confidence 
level and 5% tolerable sampling error. 
                   n =   (zα/2)2 × p × (1− p)  
                                        d
2 
                      = (1.96)
2
 ×0.50 × (1−0.50)                 
                                     (0.05)
2 
                      = 384 
Taking 10% compensation for missing or incomplete 
records it will be: n + (n×0.1) 
= 384+ (384 × 0.1) =  422 
n: sample size 
p: prevalence of drug use  
d: tolerable error 
2.8. SAMPLING PROCEDURES 
Random sampling method was used to select the 
required hospitals in Mekelle. The hospitals found in 
Mekelle were stratified as governmental and private. 
From both categories four hospitals (two governmental 
and two private) were randomly sampled. Proportional 
numbers of pregnant women were selected by systematic 
random sampling method using list of attendant pregnant 
women in each hospital as a sampling frame. 
 
 
Figure 1: Sampling procedure 
 
2.9. DATA COLLECTION AND MANAGEMENT 
2.9.1. DATA COLLECTION INSTRUMENTS 
Data abstraction format and semi- structured questioner 
was used to collect relevant data from pregnant women 
follow up medical cards and to interview pregnant 
women visiting the ANC service to address all the 
dependent and independent variables under study. 
2.9.2. RECRUITMENT AND TRAINING OF DATA 
COLLECTORS 
Data collectors who were nurses working in the selected 
health institutions during the study period and were not 
involved in prescribing were recruited. They were 
introduced to the objective of the study and trained on 
how to use the data collection instruments, the 
significance of each question in the instrument and how 
to present the questions to the respondent in a simple and 
understandable way.  
2.9.3. DATA COLLECTION 
Data was collected from January 2014 to March 2014. 
Data on socio demography and self-medication of 
pregnant women was collected using semi-structured 
questioner, and data on drugs prescribed using data 
abstraction format. 
2.9.4. DATA QUALITY ASSURANCE 
In order to develop locally acceptable way of inquiring 
and maximizing the responses by respondents; 
questionnaires were pre-tested in health institutions other 
than the study facilities before the actual data collection. 
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The pre-test helped us to rectify and revise instruments. 
The questionnaire and data abstraction format were 
translated into the common language spoken in the study 
area (Tigrigna) and back to English to ensure the 
consistency.  
2.9.5.    ETHICAL CONSIDERATIONS 
Ethical approval and clearance was obtained from 
Mekelle University, College of Health Sciences and 
Tigray Regional Health Bureau Ethical Review 
Committees. At all levels, officials were contacted and 
permission was secured.  The necessary explanation 
regarding the purpose of the study and its procedure, 
assurance of confidentiality, the right not to participate in 
the study without any consequences was done to the 
study population. Participants were assured about 
confidentiality of the information obtained in the course 
of the study in that: no personal identifiers were used and 
data was analyzed in aggregates. 
3. RESULTS 
In this study 400 pregnant women had participated. 
Majority 199 (49.8%) of the women were in the age 
group of 26-36 years with the mean age of 1.66 ± 0.64 
years. Three hundred eighty two (95.5%) of the 
respondents were married and 147 (36.8%) were 
housewives.  Majority139 (34.8%) of them were 
college/university graduated (Table-1). 
 
Table 1: Socio-demographic factor of participants (n=400), Jan-Mar 2014 
Characteristics Frequency Percentage (%) 
Age   
15-25 170 42.5 
26-36 199 49.8 
37-47 29 7.3 
>47 2 .5 
Marital status   
Married 382 95.5 
Single 13 3.3 
Divorced 5 1.3 
Educational status   
unable to read and write 48 12.0 
only read 8 2.0 
only read and write 20 5.0 
primary school complete 82 20.5 
secondary school complete 103 25.8 
college/university graduate 139 34.8 
Employment status   
Government employee 94 23.5 
non government employee 49 12.3 
Merchant 57 14.3 
Student 23 5.8 
house wife 147 36.8 
Unemployed 29 7.3 
daily worker 1 .3 
 
Of the total pregnancies; 317 (79.3%) of them were 
planned and 83 (20.8%) were unplanned.  Majority 366 
(91.5%) of the participants were vaccinated. Ninety nine 
(27%) of the pregnant women have finished the fifth 
dose of TT vaccine; of which 33 (33.3%) were from 
Meskerem hospital followed by Ayder referral hospital 
30 (30.3%), Mekelle hospital 19(19.2%) and Kalkidan 
hospital 17 (17.2%). Eighty five (23.2%) of them took 
second dose, 81 (22.1%) third dose, 66 (18.0%) and 35 
(9.6%) of the participants took fourth and first dose, 
respectively (Table-2).  
 
Table 2: Name of institutions Vs doses of TT vaccine taken by participants (n=366), Jan-Mar 2014. 
 
 
Name of Hospitals Vaccine dose 
1
st
 dose 2
nd
 dose 3
rd
 dose 4
th
 dose 5
th
 dose Total 
Ayder Referral 5 (5.2%) 17 (17.5%) 26 (26.8%) 19 (19.6%) 30 (30.9%) 97 
Mekelle  12 (4.1%) 25 (29.4%) 19 (22.4%) 10 (11.8%) 19 (22.4%) 85 
Kalkidan 14(14.9%) 26 (27.7%) 18 (19.1%) 19 (20.2%) 17 (18.1%) 94 
Meskerem 4 (4.4%) 17 (18.9%) 18 (20%) 18 (20%) 33 (36.7%) 90 
     Total 35 85 81 66 99 366 
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The result of this study showed also the extent of self 
medication among the participants. Thirty eight (9.5%) 
of the participants have utilized modern drugs and 8 
(2.0%) utilized herbs/traditional medicines to 
alleviate/treat their symptoms/diseases.  From the self 
medicated participants, majority 26 (59.1%) of them 
used analgesics. From the modern drugs self medicated, 
according to United States Food and Drug 
Administration (US FDA) fetal risk classification, 
majority 32 (84.2%) were in category C, followed by 
category B 3 (7.9%), category B/C 2 (5.3%), and 
category C/D 1 (2.7%). The main reason behind taking 
drugs without prescription was minority of the disease 23 
(5.8%).  
Bivariate Logistic regression analysis was conducted to 
explore women who were more likely to have used 
medications of any type without prescription during their 
pregnancy. Demographic factors (age, marital status, 
education and occupation of participants) were each 
tested against the outcome variable (self medications) 
use during the current pregnancy. No significant 
association was found with the participant’s age but the 
other socio-demographic factors (Marital status, 
education level and occupation) have shown significant 
association with the dependent variable (self medication) 
(Table-3). 
Multivariate logistic regression was performed for 
variables that showed significant association during 
bivariate analysis with medications use without 
prescription. The variables that were included in the final 
analysis were marital status, educational level and 
occupation of the participants. It was found that marital 
status of participants did not have significant association 
with the dependent variable; but educational level had 
showed significant association in which the illiterate 
participants were 3.7 times more to practice self 
medication (AOR 3.65 (1.31, 10.20), p=0.014) and 
participants who completed secondary school were four 
times more to practice self medication (AOR 4.03 (1.09, 
14.96), p=0.038) compared with the tertiary complete 
pregnant women. The occupation of the participants had 
also significant association with practicing self 
medication; where the participants employed in 
nongovernmental organization were 3.7 times more able 
to practice self medication (AOR 3.68 (1.11, 12.17), 
p=0.033) compared with the participants employed in 
governmental organizations (Table-3).  
 
Table 3: Binary and multivariate logistic regression analysis of Self medication Vs socio-demographic factors of the 
participants, Jan-Mar 2014. 
Characteristics of 
participants 
Self-medication, n (%) 
COR (95% CI) 
p-
value
  
AOR (95% CI) 
p- 
value
  
Yes No 
Age       
15-25 17(10.0) 153(90) 1  - - 
26-36 21 (10.6) 178 (89.4) 1.06(0.54, 2.09) 0.862 - - 
≥37 5 (16.1) 26 (83.9) 1.73(0.59, 5.10) 0.320 - - 
Marital status       
Married 37 (9.7) 345 (90.3) 1  1  
Single 4 (30.8) 9 (69.2) 4.2 (1.2,14.1) 0.23 3.78 (0.96, 14.85) 0.057 
Divorced/widowed 2 (40.0) 3 (60.0) 6.2 (1.0, 38.4) 0.049 5.09 (0.69, 37.39) 0.109 
Educational level       
Illiterate 8 (16.7) 40 (83.3) 3.22 (1.26, 8.20) 0.015 3.65 (1.31, 10.20) 0.014 
Read & write 2 (7.1) 26 (92.9) 2.92 (1.09, 7.87) 0.034 2.77 (0.92, 8.35) 0.070 
Primary complete 11 (13.4) 71 (86.6) 1.45 (0.29, 7.38) 0.654 1.38 (0.23, 8.32) 0.727 
Secondary complete 15 (14.6) 88 (85.4) 3.77 (1.28, 11.04) 0.015 4.03 (1.09, 14.96) 0.038 
Tertiary complete 7(5.0) 132 (95.0) 1  1  
Occupation of participants       
Government employee 5 (5.3) 89 (94.7) 1  1  
Non government employee 11 (22.4) 38 (77.6) 5.16 (1.68, 15.85) 0.004 3.68 (1.11, 12.17) 0.033 
Merchant 5 (8.8) 52 (91.2) 1.71 (0.48, 6.19) 0.413 0.99 (0.99, 0.25) 0.992 
Student 2 (8.7) 21 (91.3) 1.70 (0.31, 9.35) 0.545 0.82 (0.14, 4.94) 0.825 
Housewife 17 (11.6) 130 (88.4) 2.33 (0.83, 6.54) 0.109 1.32 (0.41, 4.28) 0.646 
Unemployed 3 (10.0) 27 (90.0) 1.98 (0.45, 8.82) 0.371 0.80 (0.14, 4.59) 0.803 
 
Among all the participants, 41 (10.2%) of them had 
chronic diseases. Most 21 (50.0%) of the participants 
with chronic diseases were patients living with 
HIV/AIDS who took antiretroviral therapy; from these 
20 (48.8%) were those who visited Mekelle hospital for 
antenatal care, 18 (43.9%) Ayder referral hospital and 3 
(7.3%) kalkidan hospital. Ten (23.8%) were hypertensive 
patients taking antihypertensive drugs; 7 (70%) and 3 
(30%) of them were from Ayder referral hospital and 
Mekelle hospital, respectively. From all the drugs taken 
by the patients with chronic diseases, according to US 
FDA fetal risk classification, 26 (39.4%) were from 
category C, 17 (25.8%) category D,  13 (19.7%) category 
B, and 10 (15.2%) were from category B/C. 
From all the participants, 249 (62.2%) have consumed 
one or more prescription drugs during their present 
pregnancy. The number of drugs prescribed per pregnant 
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women on average was 1.86 ±0.94. Most 103 (26%) of 
the participants were prescribed with one drug (Table-4).  
 Table 4: Number of drugs prescribed per pregnant 
women (n=249), Jan-Mar 2014. 
No. of drugs Frequency Percent 
1 103 41.4 
2 96 38.6 
3 36 14.5 
4 10 4.0 
5 3 1.2 
6 1 .4 
Total 249 100.0 
 
When all the prescribed drugs were categorized 
according to US FDA fetal risk classification; most 190 
(76.3%) were in category B, followed by category C 94 
(37.8%), category A 53 (21.3%), category C/D 23 
(9.2%), category D 22 (8.8%), category B/C 7 (2.8%),  
category A/C 3 (1.2%) and category X 1 (0.4%).  From 
the drugs prescribed, 101 (40.6%) were prescribed in 
Ayder referral hospital at which majority 80 (32.1%) 
were from category B, followed by category C 40 
(16.1%). Ninety three (37.3%) of the drugs were 
prescribed in Mekelle hospital where majority 71 
(28.5%) were in category B and 46 (18.5%) were in 
category C. Thirty one (12.4%) of them were prescribed 
in kalkidan hospital, majority 21 (8.4%) were in category 
B, and 24 (9.6%) were prescribed in Meskerem hospital 
where most 18 (7.2%) lied in category B (Table-5).  
Most 104 (26.0%) of the drugs were prescribed by 
general practitioners and the only drug from category X 
was prescribed by a nurse in Ayder referral hospital.
 
Table 5: Category of the prescribed drugs in the four study hospitals (n=249), Jan-Mar 2014. 
Category of 
prescribed drugs 
Name of Hospitals  
Ayder referral 
hospital 
Mekelle 
hospital 
Kalkidan 
hospital 
Meskerem 
hospital 
Total 
Category A 12 (4.8%) 18 (7.2%) 14 (5.6%) 9 (3.6%) 53 (21.3%) 
 Category A/C 3 (1.2%) 0(0.0%) 0 (0.0%) 0 (0.0%) 3 (1.2%) 
 Category B 80 (32.1%) 71 (28.5%) 21 (8.4%) 18 (7.2%) 190 (76.3%) 
 Category B/C 4 (1.6%) 3 (1.2%) 0 (0.0%) 0 (0.0%) 7 (2.8%) 
Category C 40 (16.1%) 46 (18.5%) 4 (1.6%) 4 (1.6%) 94 (37.8%) 
Category C/D 8 (3.2%)   9 (3.6%) 5 (2.0%) 1 (0.4%) 23 (9.2%) 
Category D 2 (0.8%) 9 (3.6%) 7 (2.8%) 4 (1.6%) 22 (8.8%) 
Category X 1 (0.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.4%) 
Total 101 (40.6%) 93 (37.3%) 31 (12.4%) 24 (9.6%) 
249 
(100.0%) 
 
 
The most commonly used prescription drugs were antibacterial drugs 146 (38.7%), followed by vitamins and minerals 
65 (17.2%) and analgesics 55 (14.6%) (Table-6). 
Table 6: Class and Percentage of the prescribed drugs (n=377), Jan-Mar 2014. 
 Class of the prescribed drugs Response 
N Percent 
antibacterial drugs 146 38.7% 
vitamin & minerals 65 17.2% 
analgsic drugs 55 14.6% 
antiemetic drugs 23 6.1% 
drugs acting in git (antacids, ppi, H-2 
blockers) 
22 5.8% 
anti retroviral drugs 13 3.4% 
antihypertensive drugs 12 3.2% 
antidiabetic drugs 3 0.8% 
antifungal drugs 3 0.8% 
sedative drugs 11 2.9% 
Glucocorticoids 14 3.7% 
other class drugs 10 2.7% 
Total  377 100.0% 
 
4. DISCUSSION 
Medications are used therapeutically for the purpose of 
diagnosis, prophylaxis and treatment of diseases. But if 
they are used inappropriately and untimely they have 
unwanted effects to the consumers. Especially when 
drugs are prescribed or self utilized during pregnancy 
high care should be given because the drugs 
administered to the pregnant women can have adverse 
effect to the unborn fetus. They can cause teratogenic, 
embryotoxic, and carcinogenic effects and also can cause 
dependency to the drugs after delivery 
7
. 
According to the result of this study from the total 400 
pregnant women participated, 366 (91.5%) were 
vaccinated. Vaccination during pregnancy is useful as 
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prophylaxis from infection of the life threatening bacteria 
called clostridium tetani to the mother and to the fetus. 
Two hundred thirty two (58%) of the participants took 
supplementation during their current pregnancy. Taking 
vitamin and mineral supplementation is beneficial to 
prevent the mother and the fetus from deficiencies of the 
vital vitamins and minerals that can cause diseases like 
anemia  to the mother and birth defects to the fetus e.g. 
deficiency of folic acid causes spina bifida (defect in 
structure of spinal cord). During pregnancy the need for 
the minerals and vitamins increases due to the fact that it 
should satisfy the need of both the mother and the fetus 
7
. 
Result of this study was very difficult to compare with 
other study results because of the following reasons: 
variation on classification of medication categories &  
variation in medication use between countries, 
inconsistency of methodology used (prescription paper 
collection, reviewing charts, reviewing medical card 
records, etc),variation in health care setting where the 
studies conducted, variation in prescribing practices 
between developing and developed countries and 
variation of prescribers qualification. 
This study showed that 9.5% of the participants have self 
medicated with modern drugs and 2.0% took traditional 
medicines/herbs to treat their symptoms. This result was 
similar to the studies done in Peru (10.5%) 
11
, Addis 
Ababa (12.4%) 
12
 and to the study done in Ethiopia 
(15.0%) 
13
. But the finding of this study was lower than 
the study done in Jimma University specialized hospital 
(20.1%) 
14
.The result of this study was very low when 
compared with the study done in Nigeria’s three general 
hospitals (72.4%) 
15
.The possible reasons could be 
sample size difference and there could be more lack of 
awareness in Jimma and Nigerian pregnant women on 
the risks of drug use during pregnancy than this study 
participant. In this study there was significant association 
between self medication and educational level; where the 
illiterate and secondary school complete participants 
practiced self medication 3.7 times (AOR 3.65 (1.31, 
10.20) with p=0.014 and 4.0 times (AOR 4.03 (1.09, 
14.96) with p=0.038, more than the tertiary complete 
participants, respectively. This might be due to lack of 
knowledge about the risk of using drugs without 
consulting health professional during pregnancy and may 
be more prone to listen advice of other lay man people 
around them than consulting health professionals. 
Occupation of participants, non government employed 
were 3.7 times (AOR 3.68 (1.11, 12.17) with p=0.033 
more to practice self medication compared with the 
government employed ones. This might be due to lack of 
right information on the harm of the drugs and may be 
economically in better status than the governmental 
employed once that can enable them to easily buy drugs. 
This study have shown that out of the total 400 
participants, 249 (62.2%) have used prescription drugs. 
With average number of drugs prescribed per pregnant 
women of 1.86±0.94. This finding was comparable with 
a study done in Ethiopia (55.2%) 
13
 and Sweden (57.6%) 
16
. 
According to the US FDA fetal risk classification of 
drugs, majority of the prescribed drugs, 190 (76.3%) 
were from category B followed by category C 94 
(37.8%), category A 53 (21.3%), category C/D 23 
(9.2%), category D 22 (8.8%) and category X 1 (0.4%).  
Some drugs are classified in category C/D, B/C, and 
A/C; depending on the time of administration (e.g. 
ibuprofen and diclofenac are classified in category C 
when administered before 30 weeks of gestation but they 
are category D drugs if administered after 30 weeks of 
pregnancy), variation on route of administration (e.g. 
methyldopa is category B drug but when administered in 
injection form it is in category C) and/or variation of 
manufacturer (e.g. magnesium sulphate is classified in 
category A or C depending on the manufacturer). 
According to one study when non steroidal anti-
inflammatory drugs are administered in the second and 
third trimester of pregnancy they are significantly 
associated with low birth weight, asthma of 18 month old 
children and maternal vaginal bleeding (17). This finding 
have shown lower prescription of harmful drugs from 
category D (8.8%) and category X (0.4%) than the study 
done in Ethiopia where 16.8% were Category D and 
7.1% Category X 
13
, but higher than the study done in 
United States (4.8%) 
18
 and Canada (5.5%) 
19
 of 
prescribing harmful drugs from category D,  but a bit 
lower pattern of prescription from category X (0.4%) 
than in United states (4.6%) 
18
 and Canada (2.5%) 
19
. 
These variations might be due to lack of knowledge, 
training  and experience of prescribers  or variation in 
sample size of this study than the studies in United States 
and Canada for prescribing category D drugs and vice-
versa for category X prescription. 
Majority of the prescribed drugs in this study were 
antibacterial medications 146 (38.7%), followed by 
vitamins and minerals 65 (17.2%), and analgesics 55 
(14.6%) (Table-6). Majority of prescribed drugs in the 
current study being antibacterial makes it comparable 
with a study done in Ethiopia (42.5%) 
13
. The possible 
reasons of higher rate of antibacterial drug prescription 
might suggest that the pregnant women’s common 
indications were microbial infections which are actually 
common in our setup. 
The current study included four hospitals with equal 
number of participants in the study (100 pregnant women 
from each). Two of the hospitals were governmental 
(Ayder referral hospital and Mekelle hospital) and the 
other two nongovernmental (Kalkidan and Meskerem 
hospital). From all the drugs prescribed majority 101 
(40.6%) of them were prescribed in Ayder referral 
hospital followed by Mekelle hospital 93 (37.3%), 
Kalkidan hospital 31 (12.4%) and Meskerem hospital 24 
(9.6%). The reason behind could be lack of updated 
knowledge of prescribers working in governmental 
hospitals than private hospitals. Moreover in private 
hospitals treatments are mostly given by senior 
professionals. In governmental hospitals commonly 
general practitioners, where majority 104 (26.0%) of the 
drugs were prescribed, and nurses are involved in 
prescription. In addition to the reasons mentioned above, 
higher number of drug prescription in Ayder referral 
hospital could be possibly it accepts referred patients 
from other governmental and nongovernmental health 
institutions that are mostly critically ill. Majority of the 
drugs prescribed in each hospital were from category B; 
32.1%, 28.5%, 8.4% and 7.2% in Ayder referral hospital, 
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Mekelle hospital, Kalkidan and meskerem hospitals, 
respectively. From the total prescribed category D drugs 
(8.8%), Majority (3.6%) were prescribed in Mekelle 
hospital followed by Kalkidan hospital (2.8%) (Table-
5).This could be due to lack of knowledge and training of 
the prescribers on the risk of prescribing drugs to 
pregnant women. Safety of majority of the prescribed 
drugs was fine to be taken during pregnancy depending 
on the risk benefit ratio. The only drug from category X 
(ergometrin) was prescribed by a nurse in Ayder referral 
hospital.  
There is no safe drug to be prescribed during pregnancy 
due to the fact that none of the drugs in the market are 
tested in pregnant women before marketing. So 
prescribing of drugs during pregnancy should be based 
on the risk benefit ratio (drugs should be prescribed to 
pregnant women if and only if the benefit outweighs the 
risk from the drug to the mother/fetus). This pattern of 
prescription by level of qualification might show that to 
prescribe relatively safe drugs during pregnancy needs 
deep knowledge and experience on pharmacological 
property of the drugs. 
5. CONCLUSION and RECOMMENDATIONS 
From this study it can be concluded that majority of the 
prescribed drugs were from category B followed by 
category C. But higher percentage was also from 
category D and one drug from category X. Extent of self 
medication was also high. 
At any time of prescribing or dispensing drugs during 
pregnancy cautions should be given. Due to the fact that 
the prescribed or self utilized drugs can harm the fetus.  
Continuous updated education should be given to the 
health professionals so that they can comply with the 
safe prescription of drugs during pregnancy based on the 
risk benefit ratio like referring to US FDA fetal risk 
classification of drugs before prescribing. Public 
education through different ways should also be achieved 
to increase awareness on safe use of drugs especially 
during pregnancy. Further studies should be done in 
health centers and health posts to see the extent of 
prescription during pregnancy. 
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